| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3191363 | Annals of Allergy, Asthma & Immunology | 2014 | 7 Pages |
Abstract
Caspase-1 inhibitors, anti-IL-18 antibodies, anti-IL-18 receptor antibodies, IL-18 binding protein, or inhibitors of genes downstream of the IL-18 signal transduction pathway may be of clinical benefit for the treatment of patients with severe asthma.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Hanako MD, Tomotaka MD, Haruki MD, Yuki MD, Yoichiro MD, Masaki MD, Yasuhiko MD, Nobutaka MD, Shin-ichi MD, Makoto MD, Tomoaki MD, Seiya MD, Paul M. MD, Tomoaki MD,